Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Observational studies have found lower rates of coronary heart disease (CHD) in postmenopausal
women who take estrogen than in women who do not, but this potential benefit has not
been confirmed in clinical trials.